Market News & Trends
West Launches New Ready-to-Use/Validated Components
West Pharmaceutical Services, Inc. recently launched Daikyo RUV (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe 2015 in Madrid, Spain. In addition, West is showcasing a range…
Ajinomoto Althea Expands Manufacturing Capabilities to ADC Fill Finish & Bioconjugation
Ajinomoto Althea, Inc. recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates…
Scientific Posters at BPI Spotlight Cutting-Edge Research
— 2015 BioProcess International Conference & Expo Unveils Over 100 Peer-Submitted Scientific Posters Featuring Innovative Concepts and Solutions…
Realizing Process Innovation in Aseptic Manufacturing: An Improved RABS Concept
(Bio-)pharmaceutical service providers in their role of manufacturing complex drug products face a difficult challenge in providing reliable and repeatable aseptic processes for ever-decreasing batch…
Astellas Pharma & Immunomic Therapeutics Announce $300-Million Worldwide Partnership for LAMP-vax Products
Immunomic Therapeutics, Inc. and Astellas Pharma Inc. recently announced they have entered into an exclusive worldwide license agreement to the LAMP-vax products for the treatment…
Merck Millipore Adds Protein Pegylation to Portfolio of Services Through Collaboration
Merck Millipore recently announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars. The new service offering enabled…
Ergomed Significantly Increases Contribution in CEL-SCI’s Phase III Trial
CEL-SCI Corporation and its Clinical Research Organization (CRO) Ergomed plc recently announced they have expanded their co-development agreement with increased activities to be undertaken by…
Enable Injections Introduces Mobile Monitoring & Larger Volume Capabilities to its Wearable Injectors
Enable Injections, the developer and manufacturer of a new wearable injector technology platform that allows patients to comfortably and easily self-administer large volume drugs subcutaneously,…
Capsugel Expands Its Successful DRcaps Capsule Platform With New Liquid-Fill Capability
Capsugel recently announced it has developed a technology that makes its vegetarian, acid-resistant DRcaps hard capsules suitable for liquid-fill applications. As a result, Capsugel’s customers…
Baxalta & Momenta Announce Initiation of Pivotal Clinical Trial for Biosimilar
Baxalta Incorporated and Momenta Pharmaceuticals, Inc. recently announced the initiation of a pivotal clinical trial in patients with chronic plaque psoriasis for M923, a biosimilar…
PharmaCyte Biotech’s Encapsulation Technology Could Address Unmet Medical Need
PharmaCyte Biotech, Inc. recently announced the second in a series of articles that will serve to educate the public on its technology and how it…
Hemispherx Biopharma Receives New Composition of Matter Patent
Hemispherx Biopharma, Inc. recently announced it received formal notice on September 21, 2015, that the European Patent Office's Examining Division granted the Company's application titled…
Cellectar Biosciences Announces Pricing of $3.3 Million Financing
Cellectar Biosciences, Inc. recently announced the pricing of a registered direct offering of 1,017,272 shares of its common stock and Series B pre-funded warrants to…
AAA Announces Positive Results From Phase III Study
Advanced Accelerator Applications S.A. recently announced that the pivotal Phase III NETTER-1 study for Lutathera (177Lu-DOTATATE) met its primary endpoint of assessing progression-free survival (PFS),…
Bayer Receives FDA Approval for First & Only Electronic Autoinjector in RRMS Treatment
Bayer HealthCare recently announced the US FDA approved BETACONNECT, the first and only electronic autoinjector in the treatment of relapsing-remitting multiple sclerosis (RRMS). BETACONNECT will…
Genisphere Closes $4 Million for Expansion of 3DNA Targeted Drug Delivery Platform
Genisphere LLC recently announced it has closed a $4-million equity round. This round of fundraising will extend and expand development of Genisphere's targeted drug delivery…
Vetter Embarks on a 300 Million Euro Investment Strategy
Ravensburg, Germany, September 30, 2015 – Vetter has announced that in keeping with its commitment to providing customers with the manufacture of high quality drug…
Ultra-Low Flow Technology for Drug Delivery
FARMINGTON, CT (September 2015) – Mott Corporation has developed a technology that controls the flow rate of a liquid or drug in devices over…
Scholar Rock Presents First Data, Announces Lead Drug Program
Scholar Rock recently announced that SRK-015 is the company’s lead drug development candidate, a niche modulator inhibiting activation of the latent myostatin precursor. The announcement…
RegeneRx Announces First Patient Enrolled in Phase III Trial
RegeneRx Biopharmaceuticals, Inc. recently announced the first patient has been enrolled in a Phase III clinical trial with RGN-259 (designated GBT-201 in Korea), its sterile,…
